The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
The Oncology Institute (TOI) delivered earnings and revenue surprises of +71.43% and +1.54%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?